CCL8
Basic information
Region (hg38): 17:34319434-34321402
Previous symbols: [ "SCYA8" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CCL8 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 6 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region ? | 1 | 1 | ||||
non coding ? | 0 | |||||
Total | 0 | 0 | 5 | 1 | 4 |
Variants in CCL8
This is a list of pathogenic ClinVar variants found in the CCL8 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-34319523-C-T | Benign (Jun 29, 2018) | |||
17-34319525-G-C | Likely benign (Jul 31, 2018) | |||
17-34319542-C-T | Benign (Jun 29, 2018) | |||
17-34319545-C-T | not specified | Uncertain significance (Dec 06, 2021) | ||
17-34319557-C-T | not specified | Uncertain significance (Sep 22, 2022) | ||
17-34319563-G-A | not specified | Uncertain significance (Jun 22, 2024) | ||
17-34319574-C-A | not specified | Uncertain significance (Mar 30, 2024) | ||
17-34320279-C-T | Benign (Jul 21, 2018) | |||
17-34320280-A-T | not specified | Uncertain significance (Jan 30, 2024) | ||
17-34320283-C-G | not specified | Uncertain significance (Feb 28, 2024) | ||
17-34320363-C-A | Benign (Apr 10, 2018) | |||
17-34320382-G-A | not specified | Uncertain significance (Jun 10, 2024) | ||
17-34320794-C-T | Benign (Aug 28, 2018) | |||
17-34320839-C-T | not specified | Uncertain significance (Sep 17, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CCL8 | protein_coding | protein_coding | ENST00000394620 | 3 | 2367 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0414 | 0.672 | 125528 | 0 | 73 | 125601 | 0.000291 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.132 | 50 | 52.7 | 0.949 | 0.00000259 | 642 |
Missense in Polyphen | 4 | 11.236 | 0.35601 | 153 | ||
Synonymous | -2.33 | 32 | 19.1 | 1.68 | 0.00000100 | 185 |
Loss of Function | 0.499 | 2 | 2.92 | 0.685 | 1.23e-7 | 35 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000353 | 0.000351 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000494 | 0.000493 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000654 | 0.0000653 |
Other | 0.000492 | 0.000490 |
dbNSFP
Source:
- Function
- FUNCTION: Chemotactic factor that attracts monocytes, lymphocytes, basophils and eosinophils. May play a role in neoplasia and inflammatory host responses. This protein can bind heparin. The processed form MCP-2(6-76) does not show monocyte chemotactic activity, but inhibits the chemotactic effect most predominantly of CCL7, and also of CCL2 and CCL5 and CCL8. {ECO:0000269|PubMed:9558113}.;
- Pathway
- Chemokine signaling pathway - Homo sapiens (human);Cytokine-cytokine receptor interaction - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.205
Intolerance Scores
- loftool
- 0.541
- rvis_EVS
- 0.7
- rvis_percentile_EVS
- 85.42
Haploinsufficiency Scores
- pHI
- 0.0461
- hipred
- N
- hipred_score
- 0.112
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.650
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- angiogenesis;monocyte chemotaxis;positive regulation of leukocyte migration;protein phosphorylation;calcium ion transport;cellular calcium ion homeostasis;exocytosis;chemotaxis;inflammatory response;signal transduction;G protein-coupled receptor signaling pathway;cell-cell signaling;response to virus;regulation of signaling receptor activity;neutrophil chemotaxis;positive regulation of GTPase activity;eosinophil chemotaxis;lymphocyte chemotaxis;chemokine-mediated signaling pathway;positive regulation of ERK1 and ERK2 cascade;negative regulation of leukocyte proliferation;cellular response to interferon-gamma;cellular response to interleukin-1;cellular response to tumor necrosis factor
- Cellular component
- extracellular space;cell
- Molecular function
- protein kinase activity;protein binding;chemokine activity;heparin binding;phospholipase activator activity;CCR2 chemokine receptor binding;CCR chemokine receptor binding